WeVote

Bill

Bill

HB 401

AN ACT relating to coverage for rapid whole genome sequencing.

2025 Regular Session

HB 401 requires Kentucky insurers to cover rapid whole genome sequencing, potentially improving genetic disease diagnosis while raising insurance costs and coverage dispute questions.

to Health Services (H)
0
WeVote Research Nonpartisan
Bill Summary · HB 401

Legislative bill overview

HB 401 would mandate insurance coverage for rapid whole genome sequencing in Kentucky. The bill appears to expand access to this advanced genetic testing technology by requiring health insurers to cover the procedure, though the full scope of coverage requirements and clinical criteria are not detailed in the available information.

Why is this important

Rapid whole genome sequencing can significantly accelerate diagnosis of genetic disorders, particularly in acute medical situations where time is critical. However, this technology is expensive and currently not universally covered by insurance, creating access disparities based on ability to pay. Mandating coverage could improve diagnostic outcomes for serious genetic conditions while potentially increasing healthcare costs for insurers and premiums for consumers.

Potential points of contention

  • Cost implications: Whole genome sequencing is expensive; mandatory coverage could substantially increase insurance costs, affecting premium rates for all policyholders
  • Medical necessity standards: Disputes over which patients qualify for rapid (versus standard-timeline) sequencing and which conditions justify the additional expense
  • Clinical evidence: Questions about whether existing medical evidence sufficiently supports rapid sequencing as standard care versus an emerging technology still being evaluated

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.